
DeltaHealth China
DeltaHealth is committed to establishing an integrated network of hospitals and clinics in China that specializes in cardiovascular care.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 2 % | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
DeltaHealth China operates as a foreign-invested healthcare provider in Shanghai, with a primary focus on cardiovascular care. The company was established in 2008 and was co-founded by Norman Chen in 2012. Mr. Chen began his healthcare career at Baxter International, later founding Asia Renal Care, Ltd., which became a prominent independent dialysis group in Asia. This background in establishing international-standard medical services informed the creation of DeltaHealth.
DeltaHealth's network consists of the Shanghai DeltaHealth Hospital, a tertiary hospital in the Qingpu district, and the DeltaWest Clinic, an outpatient facility located in the Gubei community of the Changning district. The business model centers on providing comprehensive, patient-centric medical services that cover the spectrum from prevention and screening to diagnosis, treatment, and rehabilitation. Revenue is generated through the provision of these healthcare services to patients, many of whom are covered by long-term partnerships with insurance companies. The company targets the growing middle class in Shanghai and the broader Yangtze River Delta region.
The core of DeltaHealth's service offering is its specialized cardiovascular care, including cardiology, cardiac surgery, interventional treatments, and medical imaging. The Shanghai DeltaHealth Hospital is recognized for its high volume of cardiovascular surgeries, ranking first among private hospitals in Shanghai in 2023. A key feature is the "One Heart Team" approach, developed in advisement with Columbia HeartSource, which integrates multidisciplinary care for cardiovascular diseases. Beyond its primary specialty, the company has expanded its services to include thoracic surgery, oncology, general medicine, pediatrics, and traditional Chinese medicine. A significant milestone occurred in March 2024, when Swire Pacific, a Hong Kong-listed conglomerate and an investor since 2021, acquired a controlling stake in the company, making Shanghai DeltaHealth Hospital the first wholly foreign-owned hospital in the city.
Keywords: cardiovascular care, Shanghai healthcare, private hospital, foreign-invested healthcare, cardiac surgery, thoracic surgery, oncology, outpatient clinic, medical services China, Swire Pacific, patient-centric care, DeltaHealth Hospital, DeltaWest Clinic, Norman Chen, Gubei community, Qingpu district, Yangtze River Delta healthcare, integrated medical services, JCI standards, cardiovascular rehabilitation